IPAD-DB ID | S00825 |
Name | Azure B |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 5 H 1 6 C l N 3 S |
Molecular Weight | 305.8 g/mol |
IUPAC Name | dimethyl-[7-(methylamino)phenothiazin-3-ylidene]azanium;chloride |
InChI | InChI=1S/C15H15N3S.ClH/c1-16-10-4-6-12-14(8-10)19-15-9-11(18(2)3)5-7-13(15)17-12;/h4-9H, 1-3H3;1H |
InChIKey | DNDJEIWCTMMZBX-UHFFFAOYSA-N |
Canonical SMILES | CNC1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.[Cl-] |
PubChem CID | 68275 |
DrugBank Accession Number | - |
CAS Registry Number | 531-55-5 |
Molecular Weight(Computed by SwissADME) | 305.83 |
Hac(Computed by SwissADME) | 20 |
Volume(Computed by ADMETlab 2.0) | 276.689 |
Density(Computed by ADMETlab 2.0) | 0.976 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 14 |
nHet(Computed by ADMETlab 2.0) | 4 |
fChar(Computed by ADMETlab 2.0) | 1 |
nRig(Computed by ADMETlab 2.0) | 17 |
Flexibility(Computed by ADMETlab 2.0) | 0.059 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -2.668 |
LogD(Computed by ADMETlab 2.0) | 2.104 |
logP(Computed by ADMETlab 2.0) | 2.502 |
TPSA(Computed by SwissADME) | 56.17 |
Hbond Acceptor(Computed by SwissADME) | 1 |
Hbond Donor(Computed by SwissADME) | 1 |
Rotatable Bonds(Computed by SwissADME) | 1 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.11 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 1 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |